Abrahamsson et al., "The .beta..sub.1 - and .beta..sub.2 -Adrenoceptor Affinity of Atenolol and Metoprolol: A Receptor-Binding Study Performed With Different Radioligands in Tissues from the Rat, The Guinea Pig, and Man," Biochemical Pharmacology 37(2):203-208 (1988). |
Aggerbeck et al., "Characterization of the .alpha.-Adrenoreceptor of Rat Liver Plasma Membrane. Structure Affinity relationship and role of the aralkyl substituent on the amino group," Recent Advances in the Pharmacology of Adrenoceptors: Proceedings of a Satellite Symposium of the 7th International Congress of Pharmacology held at Owens Park, Manchester pp. 345-346 (1978). |
Aggerbeck et al., "N-Aralkyl Substitution Increases the Affinity of Adrenergic Drugs for the .alpha.-Adrenoceptor in Rat Liver," Br. J. Pharmacol. 65(1):155-159 (1979). |
Auerbach et al., "Neonatal Rat Pinealocytes: Typical and Atypical Characteristics of [.sup.125 I]Iodohydroxybenzylpindolol Binding and Adenosine 3', 5'-Monophosphate Accumulation," Endocrinology 108(2):559-567 (1981). |
Aurbach et al., ".beta.-Adrenergic Receptor: Sterospecific Interaction of Iodinated .beta.-Blocking Agent with High Affinity Site," Science 186:1223-1224 (1974). |
Bakardjieva et al., "Modulation of the .beta.-Receptor Adenylate Cyclase Interactions in Cultured Chang Liver Cells by Phospholipid Enrichment," Biochemistry 18(14):3016-3023 (1979). |
Baker et al., "The Synthesis of N-Alkylated p-Chlorophentermine Derivatives and Their Effects on Release of 5-Hydroxytryptamine From Rat Striatum in Vitro," Canadian Journal of Pharmaceutical Sciences 15(4):71-74 (1980). |
Bearer et al., "Iodohydroxybenzylpindolol: Preparation, Purification, Localization of Its Iodine to the Indole Ring, and Characterization as a Partial Agonist," Molecular Pharmacology 17(3):328-338 (1980). |
Bilezikian et al., "Structure-Binding Activity Analysis of Beta-Adrenergic Amines--II. Binding to the Beta Receptor and Inhibition of Adenylate Cyclase," Biochemical Pharmacology 27(10):1455-1461 (1978). |
Braun et al., "The Interaction of Mn.sup.2+ with Turkey Erythrocyte Adenylate Cyclase," Biochimica et Biophysica Acta 705(1):55-62 (1982). |
Brown et al., ".beta.-Adrenergic Receptor Interactions: Characterization of Iodohydroxylbenzylpindolol As A Specific Ligand," J. Biol. Chem. 25(5):1232-1238 (1976). |
Brown et al., ".beta.-Adrenergic Receptor Interactions: Direct Comparison of Receptor Interaction and Biological Activity," J. Biol. Chem. 251(5):1239-1246 (1976). |
Brown et al., "Cloning and characterization of an extracellular Ca.sup.2+ -sensing receptor from bovine parathyroid," Nature 366:575-580 (1993). |
Brown et al., "Direct Determination of Ligand Interactions with Beta-Adrenergic Receptors on Intact Turkey Erythrocytes: Correlation of Binding with Biological Activity," Endocrinology 99(5):1370-1376 (1976). |
Brown et al., "Neomycin Mimics the Effects of High Extracellular Calcium Concentrations on Parathyroid Function in Dispersed Bovine Parathyroid Cells," Endocrinology 128:3047-3054 (1991). |
Burgisser et al., "Anomalous Equilibrium Binding Properties of High-Affinity Racemic Radioligands," Molecular Pharmacology 19(2):205-216 (1981). |
Bylund and Snyder, "Beta Adrenergic Receptor Binding in Membrane Preparations from Mammalian Brain," Molecular Pharmacology 12(4):568-580 (1976). |
Bylund et al., "Beta Adrenergic Receptor Labeling in Intact Animals with .sup.125 I-Hydroxybenzylpindolol," The Journal of Pharmacology and Experimental Therapeutics 201(3):644-653 (1977). |
Castedo et al., ".beta.-Adrenergic Blockers: Synthesis of R-1-[(1,1-dimethyl-2-phenylethyl) amino]-3-(3,4-dichlorophenoxy)-2-propanol," Anales De Quimica, Ser. C, 80(3):291-294 (1984). |
Chen and Brown, "The Diltiazem Analog TA-3090 Mimics the Actions of High Extracellular Ca.sup.2+ on Parathyroid Function in Dispersed Bovine Parathyroid Cells," Journal of Bone and Mineral Research 5:581-587 (1990). |
Condon et al., "Nondepressant .beta.-Adrenergic Blocking Agents. 1. Substituted 3-Amino-1-(5,6,7,8-tetrahydro-1-naphthoxy)-2-propanols," J. Med. Chem. 21(9):913-922 (1978). |
Crowther et al., ".beta.-Adrenergic Blocking Agents. 12. Heterocyclic Compounds Related to Propranolol," J. Med. Chem. 15(3):260-266 (1972). |
Dax and Partilla, "Adrenergic Ligand Liposolubility in Membranes: Direct Assessment in a Beta-Adrenergic Binding System," Molecular Pharmacology 22(1):5-7 (1982). |
Dax et al., "Quantitation of Beta Adrenergic Receptors in Rat Liver: Confounding Effect of Displaceable But Nonsterospecific Antagonist Binding," Journal of Receptor Research 2(3):267-283 (1981). |
Dempster et al., "Anabolic Actions of Parathyroid Hormone on Bone," Endocrine Reviews 14(6):690-709 (1993). |
Eckelman et al., "In vivo Competition Studies with Analgoues of 3-Quinuclidinyl Benzilate," Journal of Pharmaceutical Sciences 73(4):529-534 (1984). |
Eckelman et al., "Radiochemistry and Radiopharmaceuticals: In Vivo Receptor Binding of Iodinated Beta-Adrenoceptor Blockers," J. Nucl. Med. 21(5):436-442 (1980). |
Espinosa and Ibanez-Paniello, ".beta. Blocking Adrenergics: Synthesis and Resolution of 1-[(1,1-dimethyl-2-phenylethyl) amino]-3-aryloxy-2-propanols," Anales De Quimica, Ser. C, 77(1):22-27 (1981). |
Espinosa and Ibanez-Paniello, "Adrenergic .beta.-Blockers: Synthesis of 1-[(1,1-dimethyl-2-phenylethyl) amino]-3-aryloxy-2-propanols," Anales De Quimica, Ser. C, 77(3):361-365 (1981). |
Esplugues et al., "Experimental Evaluation of Antianginal Drugs," Revista Espanola de Fisiologia 34(1):15-20 (1978). |
Ezrailson et al., "[.sup.125 I]Iodopindolol: A New .beta. Adrenergic Receptor Probe," J. Cyclic Nucleotide Research 7(1):13-26 (1981). |
Fleming and Ross, "Reconstitution of Beta-Adenergic Receptors Into Phospholipid Vesicles: Restoration of [.sup.125 I]Iodohydroxybenzylpindolol Binding to Digitonin-Solubilized Receptors," J. Cyclic Nucleotide Research 6(6):407-419 (1980). |
Gao et al., "Radioiodination and Pharmacokinetics of Bivalent Analog of Practolol as Myocardial Imaging Agent," Nuclear Science and Techniques 6(4):238-240 (1995). |
Garrett et al., "Calcitonin-Secreting Cells of the Thyroid Express an Extracellular Calcium Receptor Gene," Endocrinology 136(11):5202-5211 (1995). |
Goretzki et al., "Absence of high-affinity binding sites for beta-adrenergic blockers and lack of adenyl cyclase stimulation to beta-adrenergic stimulators in most normal and adenomatous human thyroid tissues," Surgery 96(6):1001-1008 (1984). |
Gregory et al., "Ch. 8--The Beta-Adenergic Receptor and Adenyl Cyclase of Rabbit Ciliary Processes," in New Directions in Ophthalmic Research, edited by Sears, Yale University Press, New Haven and London, pp. 127-145 (1981). |
Guellaen et al., "Characterization and Solubilization of the .alpha.-Adrenoreceptor of Rat Liver Plasma Membranes Labeled with [.sup.3 H]Phenoxybenzamine," J. Biol. Chem. 254(21):10761-10768 (1979). |
Hanel et al., "New systemically active antimycotics from the beta-blocker category," Mycoses 38(7/8):251-264 (1995). |
Harada et al., "Studies on Uricosuric Diuretics. I. 6,7-Dichloro-5-sulfamoyl-2,3-dihydrobenzofuran-2-carboxylic Acids," Chem. Pharm. Bull. 35(8):3195-3214 (1987). |
Harden et al., "Binding of Iodinated Beta Adrenergic Antagonists to Proteins Derived from Rat Heart," Molecular Pharmacology 12:1-15 (1976). |
Heidenreich et al., "Characterization of Radiolabeled Agonist Binding to .beta.-Adrenergic Receptors in Mammalian Tissues," J. Cyclic Nucleotide Research 6(3):217-230 (1980). |
Heidenreich et al., "Effects of Magnesium and N-Ethylmaleimide on the Binding of .sup.3 H-Hydroxybenzylisoproterenol to .beta.-Adrenergic Receptors," J. Biol. Chem. 257(2):804-810 (1982). |
Homcy et al., "Beta Receptor Occupancy: Assessment in the Intact Animal," J. Clin. Invest. 65(5):1111-1118 (1980). |
Ibanez-Paniello, "Synthesis of N-substituted derivatives of 1-amino-3-(p-acetamidophenoxy)-2-propanol with potential .beta.-adrenergic blocking activity," Anales De Quimica 72(9-10):814-819 (1976). |
Innis et al., "A Simple, Sensitive and Specific Radioreceptor Assay for .beta.-Adrenergic Antagonist Drugs," Life Sciences 23(20):2031-2037 (1978). |
Insel et al., "Beta Adrenergic Receptors and Adenylate Cyclase: Products of Separate Genes?" Molecular Pharmacology 12(6):1062-1069 (1976). |
Insel and Stoolman, "Radioligand Binding to Beta Adrenergic Receptors of Intact Cultured S49 Cells," Molecular Pharmacology 14:549-561 (1978). |
Jones et al., "Synthesis and Binding to .beta.-Adrenergic Receptors of p-Aminobenzyl Analogues of Practolol and Atenolol," Journal of Pharmaceutical Sciences 81(4):397-398 (1992). |
Kaumann, "A proposal for 3 classes of agonists from relations between .beta.-adrenoceptor occupancy and positive inotropic effects in cat heart," Progress in Pharmacology 4(1):1-4 (1980). |
Kaumann, "In Kitten Ventricular Myocardium, the Inotropic Potency of an Agonist is Determined by Both Its Intrinsic Activity for the Adenylyl Cyclase and its Affinity for the .beta.-Adrenoceptors," Naunyn-Schmeideberg's Arch. Pharmacol. 317(1):13-18 (1981). |
Kleinstein et al., "Solubilization of a Mammalian .beta.-Adrenergic Receptor," Naunyn-Schmeideberg's Arch. Pharmacol. 305(3):191-200 (1978). |
Kobayashi et al., "Identification of .beta.-Adrenergic Receptor Binding Sites in Rat Brain Microvessels, Using [.sup.125 I]Iodohydroxylbenzylpindolol," Journal of Neurochemistry 36(4):1383-1388 (1981). |
Lau et al., "Subclassification of .beta.-Adrenergic Receptors in Cultured Rat Cardiac Myoblasts and Fibroblasts," Circulation Research 47(1):41-48 (1980). |
Lautens and Ruoho, "Photoaffinity labeling of the .beta.-adrenergic receptor in synaptic membranes of rat cerebral cortex and cerebellum," Brain Research 426(2):401-406 (1987). |
Law and Stafford, "The use of ultraviolet spectra and chromatographic retention data as an aid to metabolite identification," Journal of Pharmaceutical & Biomedical Analysis 11(8):729-736 (1993). |
Lee et al., "Beta-Adrenergic Receptors of Human Polymorphonuclear Leukocytes," Research Communications in Chemical Pathology and Pharmacology 31(3):453-462 (1981). |
Lewitus and Laor, "Asymmetry of Beta-Adrenoceptors in Rat Brain, Labeled by 125-I-Hydroxybenzyllpindolol," Nuclear Medicine Communications 2(3):180-182 (1981). |
Limbird and Lefkowitz, "Negative Cooperativity among .beta.-Adenergic Receptors in Frog Erythrocyte Membranes," J. Biol. Chem. 251(16):5007-5014 (1976). |
Linschoten et al., "Mapping the Turkey Erythrocyte .beta. Receptor: A Distance Geometry Approach," J. Med. Chem. 29(2):278-286 (1986). |
Lucas and Bockaert, "Use of (-)-[.sup.3 H]Dihydroalprenolol to Study Beta Adrenergic Receptor-Adenylate Cyclase Coupling in C6 Glioma Cells: Role of 5'-Guanylylimidodiphosphate," Molecular Pharmacology 13(2):314-329 (1977). |
Maguire et al., "An Agonist-Specific Effect of Guanine Nucleotides on Binding to the Beta Adrenergic Receptor," Molecular Pharmacology 12(2):335-339 (1976). |
Marinetti et al., "Beta-Adrenergic Receptors of Human Leukocytes: Studies with Intact Mononuclear and Polymorphonuclear Cells and Membranes Comparing Two Radioligands in the Presence and Absence of Chloroquine," Biochemical Pharmacology 32(13):2033-2043 (1983). |
McClure et al., "Antihypertensive .beta.-Adrenergic Blocking Agents: N-Aralkyl Analogues of 2-[3-(tert-Butylamino)-2-hydroxyproxy]-3-cyanopyridine," J. Med. Chem. 26(5):649-657 (1983). |
McDonald et al., "The Development of Beta-Adrenergic Receptors in the Visual Cortex of the Rat," Neuroscience 7(11):2649-2655 (1982). |
Meunier and Labrie, "Specificity of the .beta..sub.2 -Adrenergic Receptor Stimulating Cyclic AMP Accumulation in the Intermediate Lobe of Rat Pituitary Gland," European Journal of Pharmacology 81(3):411-420 (1982). |
Minneman et al., "A Comparison of the Beta-Adrenergic Receptor of the Turkey Erythrocyte with Mammalian Beta.sub.1 and Beta.sub.2 Receptors," Molecular Pharmacology 17(1):1-7 (1980). |
Mithal et al., "Highly Purified Sheep C-Cells Express an Extracellular Ca.sup.2+ Receptor Similar to that Present in Parathyroid," Journal of Bone and Mineral Research 9(1):S282 at abstract no. B209 (1994). |
Mukherjee et al., "Structure-Activity Relationships of Adenylate Cyclase-Coupled Beta Adrenergic Receptors: Determination by Direct Binding Studies," Molecular Pharmacology 12(1):16-31 (1971). |
Munnich et al., "Rat Liver .beta.-Adrenergic Receptors: Identification and Characterization with (-)[.sup.3 H]Dihydroalprenolol," Horm. Metab. Res. 13(1):18-21 (1981). |
Nemeth, "Regulation of cystolic calcium by extracellular divalent cations in C-cells and parathyroid cells," Cell Calcium 11:323-327 (1990). |
Nemeth and Scarpa, "Spermine Evokes the Rapid Mobilization of Cellular Ca.sup.2+ in Parathyroid Cells," Calcium-Binding Proteins in Health and Disease, Norman et al. editors, Academic Press, Inc., San Diego, pp. 33-35 (1987). |
Nemeth and Carafoli, "The role of extracellular calcium in the regulation of intracellular calcium and cell function," Cell Calcium 11:319-321 (1990). |
Nero et al., ".beta.-Adrenoceptor agonists and antagonists: conformational analysis of the ethanolamine and propanolamine side-chain," Journal of Molecular Structure (Theochem) 285:251-272 (1993). |
Neve et al., "Quantitative Analysis of the Selectivity of Radioligands for Subtypes of Beta Adrenergic Receptors," The Journal of Pharmacology and Experimental Therapeutics 238(1):46-53 (1986). |
Oshiro et al., "Synetheses of 8-Acylamino-3,4-dihydrocarbostyril Derivatives with .beta.-Adrenergic Blocking Action," Yakugaku Zasshi 104(1):28-36 (1984). |
Paietta et al., "Non-Specific Uptake of the Radioligand .sup.125 I-IHYP By Intact Human Lymphocytes: Reversal of the Uptake Process," Molecular and Cellular Endocrinology 25(3):267-276 (1982). |
Riva and Creese, "Comparison of Two Putatively Selective Radioligands for Labeling Central Nervous System .beta.-Adrenergic Receptors: Inadequacy of [.sup.3 H]Dihydroalprenolol," Molecular Pharmacology 36:201-210 (1989). |
Roberts et al., "Identification of Beta-Adrenergic Binding Sites in Rabbit Myometrium," Endocrinology 101(6):1839-1843 (1977). |
Rockson et al., "Anti-Alprenolol Antibodies in the Rabbit: A New Probe for the Study of .beta.-Adrenergic Receptor Interaction," Circulation Research 46(6):808-813 (1980). |
Rogers et al., "Calcium Receptor Expression in the Parathyroid Glands of Vitamin D-Deficient Rats is not Regulated by Plasma Caclium and 1,25(OH).sub.2 D.sub.3," Journal of Bone and Mineral Research 9(1):S409 at abstract No. C392 (1994). |
Rogers et al., "Localization of Calcium Receptor mRNA in Rat Thyroid and Parathyroid Glands Using In Situ Hybridization Histochemistry," Journal of Bone and Mineral Research 9(1):S409 at abstract No. C390 (1994). |
Rogers et al., "Pharmacological Comparison of Bovine Parathyroid, Human Parathyroid and Rat Kidney Calcium Receptors Expressed in HEK 293 Cells," Journal of Bone and Mineral Research 10(1):S483 (1995). |
Ruoho et al., "[.sup.125 I]-Iodoazidobenzylpindolol-Photolabeling of the .beta.-Adrenergic Receptor from Lymphoma Cells: Properties of the 65K and 55K Polypeptides," in Adrenergic Receptors: Molecular Properties and Therapeutic Implications, Symposium St.-Paul-de-Vence, France, Oct. 21-24, 1984, pp. 87-103 (1985). |
Ruoho et al., "Use of photolabels to probe the Na, K-ATPase and the .beta.-adrenergic receptor," Fed. Proc., Fed. Am. Soc. Exp. Biol. 42(11):2837-2841 (1983). |
Sager et al., "Adrenergic ligand binding in human serum," Biochemical Pharmacology 34(15):2812-2815 (1985). |
Sahyoun et al., "Topographic separation of adenylate cyclase and hormone receptors in the plasma membrane of toad erythrocyte ghosts," Proc. Natl. Acad. Sci. USA 74(7):2860-2864 (1977). |
Schaeffer et al., "Inhibition of Synaptosomal Accumulation of I-Norepinerphrine II: N-Aryloxyalkylphentermines, Quaternary d-Amphetamines, and 3-Aryloxypropylamines," Journal of Pharmaceutical Sciences 65(1):122-126 (1976). |
Smejkal et al., "Series of new adrenergic products," Therapie 22(6):1343-1347 (1967). |
Terasaki and Brooker, "[.sup.125 I]Iodohydroxybenzylpindolol Binding Sites on Intact Rat Glioma Cells: Evidence for .beta.-Adrenergic Receptors of High Coupling Efficiency," J. Biol. Chem. 253(15):5418-5425 (1978). |
Terasaki et al., "Quantitative relationship between .beta.-adrenergic receptor number and physiologic responses as studied with a long-lasting .beta.-adrenergic antagonist," Proc. Natl. Acad. Sci. USA 76(12):6401-6405 (1979). |
Tolkovsky and Levitzki, "Collision Coupling of the .beta.-Adrenergic Receptor with Adenylate Cyclase," Hormones and Cell Regulation, edited by Dumont and Nunez, North-Holland Biomedical Press, 2:89-105 (1978). |
Tominaga et al., "Studies on Positive Inotropic Agents. IV. Synthesis of 5-(3-Amino-2-hydroxypropoxy)-3,4-dihydro-8-hydroxy-2(1H)-quinolinone Derivatives," Chem. Pharm. Bull. 35(9):3699-3704 (1987). |
Tominaga et al., "Syntheses and .beta.-Adrenergic Blocking Activities of Carbostyril Derivatives," Chem. Pharm. Bull. 29(8):2166-2181 (1981). |
Trope et al., "Identification of Beta-Adrenergic Receptors in the Pigmented Mammalian Iris-Ciliary Body Diaphragm," Exp. Eye Res. 34(1):153-157 (1982). |
Tropea and Almon, "Definition of a Beta-Adrenergic Receptor Population in Skeletal Muscle: [.sup.125 I]Hydroxybenzylpindolol Binding," Gen. Pharmacol. 11(2):161-164 (1980). |
U'Prichard et al., "(+)-[.sup.3 H]Epinephrine and (-)-[.sup.3 H]Dihydroalprenolol Binding to .beta..sub.1 - and .beta..sub.2 -Noradrenergic Receptors in Brain, Heart, and Lung Membranes," J. Biol. Chem. 253(14):5090-5102 (1978). |
Weber and Petcher, "139. The Crystal and Molecular Structure of Hydroxybenzylpindolol," Helvetica Chimica Acta 60(4):1398-1402 (1977). |
Willcocks and Nahorski, "Binding of .sup.125 Iodohydroxybenzylpindolol to Cerebral Membranes: Association with 5-Hydroxytryptamine Recognition Sites as Well as Beta-Adrenoceptors," Biochemical Pharmacology 32(22):3311-3319 (1983). |
Wolfe and Harden, "Guanine Nucleotides Modulate the Affinity of Antagonists at .beta.-Adrenergic Receptors," J. Cyclic Nucleotide Research 7(5):303-312 (1981). |
Yamamura and Rodbell, "Hydroxybenzylpindolol and Hydroxybenzylpropranolol: Partial Beta Adrenergic Agonists of Adenylate Cyclase in the Rat Adipocyte," Molecular Pharmacology 12(5):693-700 (1976). |
Zaidi et al., "Intracellular calcium in the control of osteoclast function. II. Paradoxical elevation of cytosolic free calcium by verapamil," Biochemical and Biophysical Research Communications 167:807-812 (1990). |
Zaidi, "`Calcium Receptors` on Eukaryotic Cells with Special Reference to the Osteoclast," Bioscience Reports 10:493-507 (1990). |